Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing

Amant, Frédéric, Verheecke, Magali, Wlodarska, Iwona, Dehaspe, Luc, Brady, Paul, Brison, Nathalie, Van Den Bogaert, Kris, Dierickx, Daan, Vandecaveye, Vincent, Tousseyn, Thomas, Moerman, Philippe, Vanderstichele, Adriaan, Vergote, Ignace, Neven, Patrick, Berteloot, Patrick, Putseys, Katrien, Danneels, Lode, Vandenberghe, Peter, Legius, Eric, Vermeesch, Joris Robert·2015·JAMA Oncology

Abstract

IMPORTANCE: Noninvasive prenatal testing (NIPT) for fetal aneuploidy by scanning cell-free fetal DNA in maternal plasma is rapidly becoming a major prenatal genetic test. Similar to placental DNA, tumor DNA can be detected in the plasma, and analysis of cell-free tumor DNA can be used to characterize and monitor cancers. We show that plasma DNA profiling allows for presymptomatic detection of tumors in pregnant women undergoing routine NIPT. OBSERVATIONS: During NIPT in over 4000 prospective pregnancies by parallel sequencing of maternal plasma cell-free DNA, 3 aberrant genome representation (GR) profiles were observed that could not be attributed to the maternal or fetal genomic constitution. A maternal cancer was suspected, and those 3 patients were referred for whole-body diffusion-weighted magnetic resonance imaging, which uncovered an ovarian carcinoma, a follicular lymphoma, and a Hodgkin lymphoma, each confirmed by subsequent pathologic and genetic investigations. The copy number variations in the subsequent tumor biopsies were concordant with the NIPT plasma GR profiles. CONCLUSIONS AND RELEVANCE: We show that maternal plasma cell-free DNA sequencing for noninvasive prenatal testing also may enable accurate presymptomatic detection of maternal tumors and treatment during pregnancy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamaoncol.2015.1883

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 217

Metadata

Authors
Amant, F., Verheecke, M., Wlodarska, I., Dehaspe, L., Brady, P., Brison, N., Van Den Bogaert, K., Dierickx, D., Vandecaveye, V., Tousseyn, T., Moerman, P., Vanderstichele, A., Vergote, I., Neven, P., Berteloot, P., Putseys, K., Danneels, L., Vandenberghe, P., Legius, E., & Vermeesch, J. R.
Venue
JAMA Oncology
Published
2015-09-01
Volume
1
Issue
6
Pages
814
ISSN
2374-2437 (ISSN-L)
OpenAlex
W2145380439
Cited by
217
References
1
FWCI
25.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. https://app.cochat.ai/papers/10.1001/jamaoncol.2015.1883
The paper
Amant, F., Verheecke, M., Wlodarska, I., Dehaspe, L., Brady, P., Brison, N., Van Den Bogaert, K., Dierickx, D., Vandecaveye, V., Tousseyn, T., Moerman, P., Vanderstichele, A., Vergote, I., Neven, P., Berteloot, P., Putseys, K., Danneels, L., Vandenberghe, P., Legius, E., & Vermeesch, J. R. (2015). Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2015.1883

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.